ARCHIVES

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

NIH reiterates Position On Closed Meeting Of BSC Chairmen

September 23, 1994

DD Should Transfer Part of Breast Cancer $$ To NIH r Peer Distribution, Broder Says

December 4, 1992

Minority Demonstration Centers Concept

May 12, 1989

Cancer Prevention: NSABP Publishes P-1 Data, Finds Risk Of Breast Cancer Cut By 49 Percent

September 18, 1998

Phase III Kyprolis Trial Fails OS Primary Endpoint

August 29, 2014

FDA Grants Accelerated Approval To Mekinist-Tafinlar Combination

January 31, 2014